Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0018799 (
heart disease
)
34,133
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Acute and therapeutically uncontrollable cardiac insufficiency in a case of chronic
heart disease
with acute risk of rejection and with a record of previous transplantation or during a heart operation should be considered as an indication for implantation of an artificial heart or a ventricle-supporting system, if a donor heart is not available. Two results are expected from such an approach, restoration of adequate circulation and improvement of organ functionally providing a chance for later transplantation. Attention should be given, according to the authors' own experience, to effective surgical haemostasis.
Infections
have quite often proved to be incurable after implantation of an artificial heart and, consequently, provide a clear-cut contraindication to implantation.
...
PMID:[Current status of use of the artificial heart in combination with heart transplantation]. 305 51
Two patients with polytetrafluoroethylene (PTFE) grafts developed mycotic aneurysms at the suture lines. Both patients had chronic illnesses and recurrent infections. Attempts to surgically treat these aneurysms were unsuccessful.
Infections
involving PTFE grafts used in the management of children with congenital
heart disease
have not been reported. Problems related to diagnosis and management are discussed.
...
PMID:Septic involvement of polytetrafluoroethylene (PTFE) anastomoses producing false aneurysms: diagnosis and problems related to management. 639 29
Sinus bradycardia was observed in 10 adolescents participating in a weight loss diet conducted in a health centre. The precise cause was assessed. The subject's age ranged from 10 to 15 years and weight loss ranged from 8 to 24 kg over a period ranging from 8 to 23 weeks. None of the subjects had taken drugs with a bradycardic effect and search for toxic agents in the blood and urine was negative in all cases.
Infection
was suggested since 8 of the 10 adolescents had a rhinopharyngitis a few weeks before the discovery of bradycardia. This cause was not retained due to the lack of any signs of infection or inflammation and negative virus serology. Nutritional status was therefore retained as the most likely cause in these adolescents who were eating a diet containing < or = 1350 kcal/day. This hypothesis was supported by the results of work reported in 1970 showing arrhythmia in very low calorie diets. The effect is essentially related to the biological value of proteins in the diet, its duration and the initial weight of the subjects. In addition bradycardia is frequently seen in subjects taking hypocaloric diets or with anorexia nervosa and should be considered as an adaptation to hypometabolism rather than a true
heart disorder
. Thus the biological value of the proteins and the mineral status should be taken into consideration during the course of low calorie diets, even though bradycardia is frequent and does not require a specific treatment. Therefore heart rate and decreasing rate of weight loss should be carefully followed during the course of low calorie diets.
...
PMID:[Bradycardia during treatments of weight loss]. 750 8
As a result of hypoxia following right-to-left shunts, cerebral bacterial spreading and an altered blood-brain-barrier permeability, brain abscesses (BA) are typical complications in patients with cyanotic congenital
heart disease
. In 483 prospectively followed patients the incidence of BA was 0.45%/year. It was higher (0.57%/year) for patients with tetralogy of Fallot where the cumulative risk within the first two decades of life was 12.1 +/- 1.7%. The risk of BA complicating cyanotic
heart disease
is inconstant and continuously increasing up to approximately age 12 (instantaneous risk at that time: 1.75 +/- 0.12%), decreasing thereafter. With respect to etiology, infectious endocarditis, infections per continuitatem, bacterial meningitis, bacterial lung diseases with intrapulmonary shunts, and thromboembolic complications of systemic infections have to be differentiated. The stepwise diagnosis includes CCT to demonstrate the typical contrast enhancement and a lumbar puncture which shows granulocytic pleocytosis. If the cerebral spinal fluid fails to demonstrate the typical findings, cerebral angiography may be necessary to exclude a malignant vascularized neoplasma. In cases of doubt, stereotactic cerebral biopsy should be performed. Optimal antibiotic therapy after determining the minimal bactericidal concentration and combination of antibiotics is of utmost prognostic significance. Cranial computed tomography should be repeated after 6, 14, and 24 days.
Infections
resistant to antibiotics may necessitate local instillation of antibiotics.
...
PMID:[Brain abscess in patients with cyanotic heart defects]. 751 30
We assessed the long-term results of our experience with 109 patients with end-stage cardiopulmonary disease who underwent primary combined heart-lung transplantation at Stanford University Medical Center between March 1981 and January 1994. Average recipient age was 31 +/- 10 years (mean +/- standard deviation) median, 31 years; range, 1 month to 52 years. Recipient diagnoses included primary pulmonary hypertension (31%), Eisenmenger's syndrome (39%), complex congenital
heart disease
(8%), cystic fibrosis (14%), bronchiectasis (2%), and emphysema (3%). Immunosuppression was with cyclosporine and a tapering regimen of corticosteroids. In 1986 azathioprine was added, and since 1987 induction therapy with OKT3 has been employed. Actuarial survival rates at 1, 5, and 10 years were 68% +/- 4.6%, 43% +/- 5.4%, and 23% +/- 8.1%, respectively (mean +/- 1 standard error of the mean). Fourteen deaths occurred in the hospital for an operative mortality rate of 12.8% +/- 3.3%, and 61 deaths occurred overall. Causes of death included hemorrhage (five patients), infection (21), rejection (one), nonspecific pulmonary failure (four), graft coronary artery disease (six), and obliterative bronchiolitis (eight).
Infection
, rejection, and obliterative bronchiolitis were the major complications. Only 20% +/- 3.9% of patients were free from any infection 3 months after transplantation. Heart and lung rejection commonly occurred asynchronously; actuarial estimates of freedom from isolated lung rejection at 1 and 5 years were 47% +/- 5.2% and 40% +/- 5.6%, respectively. For simultaneous heart and lung rejection these estimates were 87% +/- 3.5% and 86% +/- 3.8%, and for isolated heart rejection 63% +/- 5.1% and 51% +/- 6.4%, respectively. Although graft coronary artery disease developed less frequently than in patients after isolated heart transplantation (90% +/- 4.6% of patients were free of graft coronary artery disease at 5 years), obliterative bronchiolitis remains a major long-term complication and cause of morbidity and mortality. Actuarial estimates of freedom from obliterative bronchiolitis at 1, 5, and 10 years were 71% +/- 5.1%, 51% +/- 6.1%, and 42% +/- 7.8%, respectively. These results show satisfactory early and medium-term outcome after combined heart-lung transplantation but also underscore that much progress is needed in controlling infection, rejection, and obliterative bronchiolitis, all of which remain as major impediments to long-term survival.
...
PMID:Long-term results of combined heart-lung transplantation: the Stanford experience. 786 27
Infection
is a serious cause of morbidity and mortality in the cardiac transplant patient. Early infections within the first month after transplantation are usually caused by nosocomial pathogens, such as Pseudomonas aeruginosa, Staphylococcus aureus, Enterococci, and members of Enterobacteriaceae and include pneumonia, urinary-tract and would infections, and bacteremia associated with the use of intravascular devices. Late infections, usually occurring after the first month and within the first year of transplantation, are commonly caused by cytomegalovirus, Pneumocystis carinii, Legionella, and fungi. Because cardiac transplantation has become a well-established treatment for patients with end-stage
heart disease
, more physicians will be treating these patients and will need to be familiar with the types of infectious complications associated with transplantation.
...
PMID:Cardiac transplantation and related infections. 801 80
The causes of death in 140 patients (30 male and 110 female) with rheumatoid arthritis (RA) at Kawasaki Municipal Hospital are analyzed. Autopsies were performed in 58%. The causes of death were infection (25.7%),
heart disease
(20.0%), renal failure (10.7%), cerebrovascular disease (10.0%), and respiratory failure (8.5%). The causes of death in RA patients were compared with those of 243 non-rheumatoid patients.
Infection
, congestive heart failure, renal failure and respiratory failure were more common causes of death in RA than in the control group. It should be noted that neoplasms are infrequent causes of death in patients with RA. The survival time (onset to death) of RA patients appears to be increasing year by year.
...
PMID:[Causes of death in 140 patients with rheumatoid arthritis]. 805 26
Twenty children were treated for infective endocarditis (IE) at Our Lady's Hospital for Sick Children during an eleven year period from January 1980 to December 1990. One child had I.E. on two occasions due to different microorganisms. Two had Down syndrome. Congenital heart disease (CHD) was the single most common underlying condition and there was none with rheumatic heart disease. Two had no clinically recognised cardiac anomaly. 13/20 (65%) had acyanotic
heart disease
and 5/20 (25%) had cyanotic CHD. Among the acyanotic group, ventricular septal defect was most common (6/13); followed by aortic lesions (4/13). There was one case each of coarctation of aorta, patent ductus arteriosus and interrupted aortic arch. Transposition of the great arteries was most common among the cyanotic group (3/5). Four children in the cyanotic group had systemic to pulmonary artery shunts; Blalock Taussig (2), Waterston (1), and aortopulmonary (1).
Infection
was caused by Streptococcus viridans in 10/20 (50%) and Staphylococcus aureus in 7/20 (35%). Kingella Kingae, Neisseria meningitidis and Streptococcus faecalis were the pathogens in the remainder (15%). Vegetations were detected by echocardiography in 12/19 (63%). The mean duration of antibiotic treatment was 5 weeks (1 day-18 weeks). Surgical intervention was necessary in 4 children (20%). Fifteen children (75%) survived and the mean follow up period was 22.6 months (15 days-6 1/2 years). The overall mortality was 25%.
...
PMID:Eleven year review of infective endocarditis. 805 46
Cardiac transplantation is an effective therapeutic modality in children, with results comparable to those of adults (5-year actuarial survival, 67 +/- 2%).
Infection
and rejection are the most frequent long-term complications. Cardiac transplantation provides excellent functional results for many children with severe congenital or acquired
heart disease
.
...
PMID:Pediatric cardiac transplantation. 806 46
Enteroviruses are ubiquitous, and most individuals encounter numerous serotypes during their lifetime.
Infection
of the heart is an unusual occurrence but enteroviruses are nevertheless the commonest viral agents of acute myocarditis. The introduction of new serological and molecular virological detection methods has improved the diagnosis of acute enteroviral
heart disease
and has also provided information on its epidemiology and pathogenesis. There remains, however, much debate on whether cardiac damage results directly from viral infection of myocytes and the ensuing immune response, or indirectly from autoimmune mechanisms. Enteroviruses are also associated with chronic cardiac disease, most notably chronic dilated cardiomyopathy. Recently the strength of this associated has been somewhat weakened by conflicting experimental evidence, but this is still an open question. Further studies are required to delineate the true role of enteroviruses in acute and chronic myocardial disease, to understand its pathogenesis more completely, and to apply this knowledge to the development of preventive or therapeutic treatment regimens.
...
PMID:Enteroviruses and heart disease. 824 41
<< Previous
1
2
3
4
5
6
7
8
Next >>